Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial)
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Exenatide (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions; Therapeutic Use
- Acronyms EXAMI
- 02 Sep 2015 Results presented at the ESC Congress 2015: Annual Congress of the European Society of Cardiology
- 07 Sep 2012 Status changed from active, no longer recruiting to completed, based on presentation of results at the ESC Congress 2012.
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.